About
Dr. Kai Luecke is a Hematologist focused on diagnosing and managing a spectrum of blood disorders, from anemias and clotting issues to blood cancers. Practicing at a specialized cancer centre or hospital department in Surrey, BC, he is part of a dedicated healthcare team committed to providing comprehensive blood disorder treatment and cancer care. His practice aligns with the standards set by the College of Physicians and Surgeons of British Columbia (CPSBC), ensuring quality and safety in every aspect of patient care. Dr. Luecke addresses a wide array of benign and malignant hematologic disorders, offering both diagnostic expertise and therapeutic interventions to improve patient outcomes and quality of life.
He graduated with a Medical Degree from Universitaet Regensburg in Germany in 2003 and completed extensive postgraduate training in Hematology (Blood Disorders). He holds certifications including those from the Royal College of Physicians and Surgeons of Canada, reflecting his commitment to maintaining high standards of medical excellence and continuous professional development. His training has equipped him with the latest knowledge and skills necessary to deliver advanced hematology services.
Dr. Luecke’s clinical philosophy emphasizes multidisciplinary care, evidence-based treatment approaches, and supporting patients and their families throughout their healthcare journey. He is dedicated to advancing research in blood disorders and providing personalized treatment plans tailored to each patient's unique needs. Serving the Surrey community, he is fluent in English and German, ensuring clear communication and compassionate care for diverse patient populations.
Dr. Kai Luecke has expertise in managing a wide range of conditions, including:
Benign Hematologic (Non-Cancerous Blood) Disorders Managed
- Iron Deficiency Anemia: A common type of anemia caused by insufficient iron, leading to reduced red blood cell production and oxygen-carrying capacity.
- Thrombophilia & Acquired Clotting Disorders (e.g., DVT/PE management, Antiphospholipid Syndrome): Conditions that increase the tendency to form blood clots, requiring anticoagulation therapy and management.
- Vitamin B12 & Folate Deficiency Anemias: Anemias resulting from a lack of vitamin B12 or folate, essential for red blood cell formation.
Hematologic Malignancies (Blood Cancers) Treated
- Acute Lymphoblastic Leukemia (ALL): A type of cancer of the blood and bone marrow that affects white blood cells called lymphocytes, common in children but also occurs in adults.
- Hodgkin Lymphoma: A cancer of the lymphatic system, part of the immune system, characterized by the presence of Reed-Sternberg cells.
- Non-Hodgkin Lymphoma (NHL) (e.g., Diffuse Large B-Cell, Follicular, Mantle Cell): A diverse group of blood cancers that develop from lymphocytes, with many different subtypes requiring tailored treatments.
This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Kai Luecke or your referring physician.
- Diagnosis & Management of Multiple Myeloma, Waldenström's Macroglobulinemia & Other Plasma Cell Dyscrasias: Specialized care for cancers arising from plasma cells, utilizing novel agents, chemotherapy, and supportive care, including stem cell transplant coordination.
- Second Opinion Consultations for Cancer & Blood Disorders: Providing expert second opinions on complex diagnoses and proposed treatment plans to ensure informed decision-making.
- Management of Bleeding Disorders (Hemophilia, Von Willebrand Disease, Platelet Function Disorders): Care for inherited and acquired conditions that affect the body's ability to form blood clots properly, including factor replacement therapies.
- Management of Myelodysplastic Syndromes (MDS): Diagnosis and treatment of bone marrow failure disorders, including supportive care, growth factors, and disease-modifying therapies.
- Management of Myeloproliferative Neoplasms (MPN) (Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis): Treatment strategies to control blood counts, manage symptoms, and prevent complications associated with these chronic bone marrow disorders.
- Performance Status Assessment & Treatment Eligibility Evaluation: Evaluating a patient's overall fitness and ability to tolerate specific anti-cancer treatments.
- Diagnosis & Treatment of Lymphomas (Hodgkin & Various Non-Hodgkin Subtypes): Tailored treatment strategies for cancers of the lymphatic system, including chemotherapy, immunotherapy, targeted agents, and radiotherapy coordination.
Note: This list provides a general overview of services offered in Hematology (Blood Disorders). Treatment plans are highly individualized. Dr. Luecke provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Luecke or your healthcare team for details relevant to your care.
All medical services and treatments are provided in accordance with the standards of practice set by the College of Physicians and Surgeons of British Columbia (CPSBC) and relevant cancer care guidelines. A referral is required.
Dr. Luecke practices primarily at a specialized cancer centre located in the West Newton, Strawberry Hill neighborhood of Surrey, BC. The facility is easily accessible via Highway 1 and is close to landmarks such as Guildford Town Centre. Public transit options include TransLink services, including the SkyTrain Expo Line and bus routes, making access convenient for patients from surrounding areas. The centre is wheelchair accessible, providing barrier-free entry and facilities. Paid parking options are available nearby to accommodate visitors and patients attending appointments.
- Are consultations and treatments with Dr. Luecke, an Hematologist, covered by Medical Services Plan (MSP) in BC?
- Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Hematologist such as Dr. Luecke are generally covered by Medical Services Plan (MSP) in BC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Medical Services Plan (MSP), Dr. Luecke's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.
- Do I need a referral to see Dr. Luecke, an Hematologist?
- Yes, a referral from your family physician or another specialist is almost always required to see an Hematologist like Dr. Luecke for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.
- Does Dr. Luecke participate in or offer access to clinical trials?
- Many oncologists and hematologists are involved in clinical research to advance cancer treatment and care for blood disorders, as participation in clinical trials can offer access to new and investigational treatments. Dr. Luecke is actively involved in clinical trials and may discuss relevant trial options with you if you are eligible and it is appropriate for your condition. You can ask Dr. Luecke if there are any suitable clinical trials available for your condition, either at Dr. Luecke's institution or through collaborative research networks. He can provide information or refer you for consideration.
- How will treatment decisions be made for my condition by Dr. Luecke?
- Treatment decisions in oncology and hematology are highly personalized and made collaboratively. Dr. Luecke will consider many factors, including the type and stage of your cancer or blood disorder, your overall health, genetic markers of the disease (if applicable), current treatment guidelines, and importantly, your personal preferences and values. Often, cases are discussed in multidisciplinary team meetings (tumor boards) with other specialists to ensure a comprehensive approach. You will be an active participant in this decision-making process.
13750 96 Ave, Fraser Valley Cancer Centre, BC-Cancer Agency
Surrey, BC V3V 1Z2
Phone: (604) 930-2098 | Fax: (604) 587-4312
The facility is wheelchair accessible.
Dr. Luecke is a licensed Hematologist regulated by the College of Physicians and Surgeons of British Columbia (CPSBC) under the Health Professions Act in BC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.
Verify registration with the College of Physicians and Surgeons of British Columbia (CPSBC): https://www.cpsbc.ca/public/registrant-directory/search-result/331683/Luecke%2CKai